Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $324.15 million. The enterprise value is $357.26 million.
| Market Cap | 324.15M |
| Enterprise Value | 357.26M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026, before market open.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 9.19 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Current Share Class | 9.19M |
| Shares Outstanding | 9.19M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | -3.60% |
| Owned by Insiders (%) | 31.29% |
| Owned by Institutions (%) | 18.24% |
| Float | 3.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 106.11 |
| PS Ratio | 2.95 |
| Forward PS | 5.34 |
| PB Ratio | 40.70 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 71.97 |
| P/OCF Ratio | 56.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.03, with an EV/FCF ratio of 79.32.
| EV / Earnings | n/a |
| EV / Sales | 3.25 |
| EV / EBITDA | 28.03 |
| EV / EBIT | 34.82 |
| EV / FCF | 79.32 |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 6.12.
| Current Ratio | 2.58 |
| Quick Ratio | 2.24 |
| Debt / Equity | 6.12 |
| Debt / EBITDA | 3.64 |
| Debt / FCF | 10.78 |
| Interest Coverage | 1.41 |
Financial Efficiency
Return on equity (ROE) is -1.32% and return on invested capital (ROIC) is 9.34%.
| Return on Equity (ROE) | -1.32% |
| Return on Assets (ROA) | 7.64% |
| Return on Invested Capital (ROIC) | 9.34% |
| Return on Capital Employed (ROCE) | 18.11% |
| Weighted Average Cost of Capital (WACC) | 10.78% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | -$296,435 |
| Employee Count | 108 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 2.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.27% in the last 52 weeks. The beta is 1.16, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | +7.27% |
| 50-Day Moving Average | 32.43 |
| 200-Day Moving Average | 24.05 |
| Relative Strength Index (RSI) | 76.38 |
| Average Volume (20 Days) | 243,634 |
Short Selling Information
The latest short interest is 280,418, so 3.05% of the outstanding shares have been sold short.
| Short Interest | 280,418 |
| Short Previous Month | 211,128 |
| Short % of Shares Out | 3.05% |
| Short % of Float | 7.45% |
| Short Ratio (days to cover) | 0.82 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $109.81 million and -$32.01 million in losses. Loss per share was -$3.69.
| Revenue | 109.81M |
| Gross Profit | 102.16M |
| Operating Income | 10.26M |
| Pretax Income | -286,274 |
| Net Income | -32.01M |
| EBITDA | 12.75M |
| EBIT | 10.26M |
| Loss Per Share | -$3.69 |
Balance Sheet
The company has $15.42 million in cash and $48.53 million in debt, with a net cash position of -$33.11 million or -$3.60 per share.
| Cash & Cash Equivalents | 15.42M |
| Total Debt | 48.53M |
| Net Cash | -33.11M |
| Net Cash Per Share | -$3.60 |
| Equity (Book Value) | 7.93M |
| Book Value Per Share | 0.86 |
| Working Capital | 19.71M |
Cash Flow
In the last 12 months, operating cash flow was $5.69 million and capital expenditures -$1.19 million, giving a free cash flow of $4.50 million.
| Operating Cash Flow | 5.69M |
| Capital Expenditures | -1.19M |
| Depreciation & Amortization | 2.49M |
| Net Borrowing | n/a |
| Free Cash Flow | 4.50M |
| FCF Per Share | $0.49 |
Margins
Gross margin is 93.03%, with operating and profit margins of 9.34% and -29.15%.
| Gross Margin | 93.03% |
| Operating Margin | 9.34% |
| Pretax Margin | -0.26% |
| Profit Margin | -29.15% |
| EBITDA Margin | 11.61% |
| EBIT Margin | 9.34% |
| FCF Margin | 4.10% |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.59% |
| Shareholder Yield | -1.59% |
| Earnings Yield | -9.88% |
| FCF Yield | 1.39% |
Analyst Forecast
The average price target for Sanara MedTech is $35.00, which is -0.79% lower than the current price. The consensus rating is "Hold".
| Price Target | $35.00 |
| Price Target Difference | -0.79% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 13.88% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Sanara MedTech has an Altman Z-Score of 3.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.05 |
| Piotroski F-Score | 6 |